Published in Am J Kidney Dis on April 01, 2010
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36
Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med (2013) 7.98
Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int (2011) 6.01
Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87
Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis (2010) 2.41
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2011) 1.88
Advances in glomerular filtration rate-estimating equations. Curr Opin Nephrol Hypertens (2010) 1.49
GFR estimation: from physiology to public health. Am J Kidney Dis (2014) 1.49
A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int (2015) 1.46
Estimated Glomerular Filtration Rate (eGFR): A Serum Creatinine-Based Test for the Detection of Chronic Kidney Disease and its Impact on Clinical Practice. Oman Med J (2012) 1.18
Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One (2016) 1.17
The applicability of eGFR equations to different populations. Nat Rev Nephrol (2013) 1.10
Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting. BMJ Open (2011) 1.10
Chronic kidney disease screening methods and its implication for Malaysia: an in depth review. Glob J Health Sci (2015) 1.09
Methods of Estimating GFR - Different Equations Including CKD-EPI. Clin Biochem Rev (2011) 1.06
Comparison of CKD awareness in a screening population using the Modification of Diet in Renal Disease (MDRD) study and CKD Epidemiology Collaboration (CKD-EPI) equations. Am J Kidney Dis (2011) 1.04
Addressing the global burden of chronic kidney disease through clinical and translational research. Trans Am Clin Climatol Assoc (2014) 1.01
Comparing the association of GFR estimated by the CKD-EPI and MDRD study equations and mortality: the third national health and nutrition examination survey (NHANES III). BMC Nephrol (2012) 0.99
Clinical evaluation of analytical variations in serum creatinine measurements: why laboratories should abandon Jaffe techniques. BMC Nephrol (2012) 0.93
Estimated GFR and incident cardiovascular disease events in American Indians: the Strong Heart Study. Am J Kidney Dis (2012) 0.92
Chronic kidney diseases in mixed ancestry south African populations: prevalence, determinants and concordance between kidney function estimators. BMC Nephrol (2013) 0.92
(99m)Tc-DTPA renal dynamic imaging method may be unsuitable to be used as the reference method in investigating the validity of CDK-EPI equation for determining glomerular filtration rate. PLoS One (2013) 0.92
Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar. Kidney Int (2014) 0.88
Estimated glomerular filtration rate as an independent predictor of atherosclerotic vascular disease in older women. BMC Nephrol (2012) 0.86
25-Hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study. BMC Nephrol (2012) 0.86
A comparison of CKD-EPI estimated glomerular filtration rate and measured creatinine clearance in recently admitted critically ill patients with normal plasma creatinine concentrations. BMC Nephrol (2013) 0.86
Controversies in chronic kidney disease staging. Clin Biochem Rev (2011) 0.85
Comparison of two creatinine-based equations for predicting decline in renal function in type 2 diabetic patients with nephropathy in a korean population. Int J Endocrinol (2013) 0.85
Chronic kidney disease: the CKD-EPI equation to estimate GFR-better alchemy? Nat Rev Nephrol (2011) 0.83
Estimating glomerular filtration rate using the chronic kidney disease-epidemiology collaboration creatinine equation: better risk predictions. Circ Heart Fail (2012) 0.82
Biomarkers in chronic kidney disease, from kidney function to kidney damage. World J Nephrol (2015) 0.82
Awareness of chronic kidney disease in Austria: a frequently under-recognized clinical picture. Wien Klin Wochenschr (2013) 0.81
Implications of the CKD-EPI GFR estimation equation in clinical practice. Clin J Am Soc Nephrol (2010) 0.81
The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol (2016) 0.81
Screening for decreased glomerular filtration rate and associated risk factors in a cohort of HIV-infected patients in a middle-income country. PLoS One (2014) 0.81
Limited referral to nephrologists from a tertiary geriatric outpatient clinic despite a high prevalence of chronic kidney disease and anaemia. BMC Geriatr (2012) 0.80
Vitamin D Level is Associated with Increased Left Ventricular Mass and Arterial Stiffness in Older Patients with Impaired Renal Function. Med Sci Monit (2015) 0.80
Comparison of two creatinine-based estimating equations in predicting all-cause and cardiovascular mortality in patients with type 2 diabetes. Diabetes Care (2012) 0.79
Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network. Kidney Int (2013) 0.79
Exploration of chronic kidney disease prevalence estimates using new measures of kidney function in the health survey for England. PLoS One (2015) 0.79
Smoking increases the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease. Kidney Int (2015) 0.78
Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns-NHANES 2007-2012. BMJ Open Diabetes Res Care (2016) 0.77
Prognostic abilities of different calculation formulas for the glomerular filtration rate in elderly Chinese patients with coronary artery disease. Clin Interv Aging (2013) 0.77
The Impact of Creatinine Clearance Rate, Daily Urinary Albumin, and Their Joint Effect on Predicting Death in Diabetic Inpatients After Discharge: An Observational Study. Medicine (Baltimore) (2016) 0.77
Protective effects of methanolic extract form fruits of Lycium ruthenicum Murr on 2,2'-azobis (2-amidinopropane) dihydrochloride-induced oxidative stress in LLC-PK1 cells. Pharmacogn Mag (2014) 0.77
The impact of 177Lu-octreotide therapy on 99mTc-MAG3 clearance is not predictive for late nephropathy. Oncotarget (2016) 0.76
A Case for Early Screening for Diabetic Kidney Disease. Cardiorenal Med (2011) 0.76
Development and Evaluation of a Semi-automated Segmentation Tool and a Modified Ellipsoid Formula for Volumetric Analysis of the Kidney in Non-contrast T2-Weighted MR Images. J Digit Imaging (2016) 0.75
A Cost-Benefit and Accurate Method for Assessing Microalbuminuria: Single versus Frequent Urine Analysis. Int J Hypertens (2013) 0.75
Impact on cardiovascular risk follow-up from a shift to the CKD-EPI formula for eGFR reporting: a cross-sectional population-based primary care study. BMJ Open (2013) 0.75
Chronic kidney disease - an exemplar for collaboration between the clinic and the laboratory. Clin Biochem Rev (2011) 0.75
A protocol for the identification and validation of novel genetic causes of kidney disease. BMC Nephrol (2015) 0.75
Association of anthropometric measures with kidney disease progression and mortality: a retrospective cohort study of pre-dialysis chronic kidney disease patients referred to a specialist renal service. BMC Nephrol (2016) 0.75
Renal function assessment in atrial fibrillation: Usefulness of chronic kidney disease epidemiology collaboration vs re-expressed 4 variable modification of diet in renal disease. World J Cardiol (2015) 0.75
Estimated Glomerular Filtration Rate versus Albuminuria in the Assessment of Kidney Function: What's More Important? Clin Biochem Rev (2014) 0.75
Initial choice of antihypertensive on long-term cardiovascular outcomes in CKD. Clin J Am Soc Nephrol (2012) 0.75
Non-linear association of serum 25-hydroxyvitamin D with urinary albumin excretion rate in normoalbuminuric subjects. BMC Nephrol (2014) 0.75
Periodontal disease and chronic kidney disease among Aboriginal adults; an RCT. BMC Nephrol (2015) 0.75
Strategies for BP Control in Developing Countries and Effects on Kidney Function. Clin J Am Soc Nephrol (2016) 0.75
[Diabetic kidney disease - Update 2016]. Wien Klin Wochenschr (2016) 0.75
Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med (2013) 7.98
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26
TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest (2007) 4.77
Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol (2003) 4.15
Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial. Am J Kidney Dis (2011) 3.81
Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Am J Kidney Dis (2011) 3.29
How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ (2008) 3.00
Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol (2004) 2.66
Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med (2002) 2.54
Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int (2004) 2.29
Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol (2005) 2.23
Relationship between dialysis modality and mortality. J Am Soc Nephrol (2008) 2.06
Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Sci Transl Med (2014) 2.02
Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis (2004) 1.94
Is low birth weight an antecedent of CKD in later life? A systematic review of observational studies. Am J Kidney Dis (2009) 1.94
Reduction in cardiovascular death after kidney transplantation. Transplantation (2010) 1.89
HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol (2010) 1.89
Pyridorin in type 2 diabetic nephropathy. J Am Soc Nephrol (2011) 1.79
Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis (2002) 1.78
Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population. Am J Kidney Dis (2011) 1.71
Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J Am Coll Cardiol (2006) 1.67
Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy. J Am Soc Nephrol (2011) 1.66
Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Am J Kidney Dis (2004) 1.62
Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practice. Nephrol Dial Transplant (2010) 1.62
Macrophage accumulation in human progressive diabetic nephropathy. Nephrology (Carlton) (2006) 1.51
Untreated hypertension among Australian adults: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust (2003) 1.44
Prospective psychosocial monitoring of living kidney donors using the SF-36 health survey. Transplantation (2003) 1.44
Native arteriovenous fistula blood flow and resistance during hemodialysis. Am J Kidney Dis (2003) 1.43
Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant (2007) 1.42
Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol Dial Transplant (2004) 1.42
Atherosclerosis and folic acid supplementation trial in chronic renal failure: baseline results. Nephrology (Carlton) (2004) 1.38
Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11). Diabetes Care (2009) 1.37
Home hemodialysis and mortality risk in Australian and New Zealand populations. Am J Kidney Dis (2011) 1.37
The role of macrophages in allograft rejection. Transplantation (2005) 1.32
Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation (2003) 1.32
Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation. Kidney Int (2003) 1.30
Implementing iron management clinical practice guidelines in patients with chronic kidney disease having dialysis. Med J Aust (2006) 1.28
Prevalence of albuminuria in Australia: the AusDiab Kidney Study. Kidney Int Suppl (2004) 1.26
Health-related quality of life in Australian adults with renal insufficiency: a population-based study. Am J Kidney Dis (2003) 1.24
Epidemiology of diabetic nephropathy. Contrib Nephrol (2011) 1.18
Prevention of chronic kidney and vascular disease: toward global health equity--the Bellagio 2004 Declaration. Kidney Int Suppl (2005) 1.16
Barriers to timely arteriovenous fistula creation: a study of providers and patients. Am J Kidney Dis (2011) 1.15
Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol Dial Transplant (2009) 1.14
Trends in hemodialysis vascular access from the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) 2000 to 2005. Am J Kidney Dis (2007) 1.14
A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis. J Am Soc Nephrol (2007) 1.13
The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis. J Am Soc Nephrol (2004) 1.12
IL-18 contributes to renal damage after ischemia-reperfusion. J Am Soc Nephrol (2008) 1.11
Limited knowledge of kidney disease in a survey of AusDiab study participants. Med J Aust (2008) 1.11
Blockade of p38alpha MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis. J Am Soc Nephrol (2003) 1.08
Optimal hemodialysis vascular access in the elderly patient. Semin Dial (2012) 1.05
Risk factors for peritoneal dialysis-related peritonitis: can we reduce the incidence and improve patient selection? Nephrology (Carlton) (2007) 1.04
Arterial function after successful renal transplantation. Kidney Int (2004) 1.04
Time and exercise improve phosphate removal in hemodialysis patients. Am J Kidney Dis (2004) 1.03
The treatment of acute antibody-mediated rejection in kidney transplant recipients-a systematic review. Transplantation (2012) 1.03
Identification of alternatively activated macrophages in new-onset paediatric and adult immunoglobulin A nephropathy: potential role in mesangial matrix expansion. Histopathology (2011) 1.02
Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trial. Nephrology (Carlton) (2011) 1.00
Does monthly native arteriovenous fistula blood-flow surveillance detect significant stenosis--a randomized controlled trial. Nephrol Dial Transplant (2006) 1.00
Activation of the extracellular-signal regulated protein kinase pathway in human glomerulopathies. J Am Soc Nephrol (2004) 1.00
The effects of a low-carbohydrate ketogenic diet and a low-fat diet on mood, hunger, and other self-reported symptoms. Obesity (Silver Spring) (2007) 0.99
Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney. Kidney Int (2003) 0.99
Day-to-day variability in spot urine albumin-creatinine ratio. Am J Kidney Dis (2013) 0.98
Association between albuminuria and proteinuria in the general population: the AusDiab Study. Nephrol Dial Transplant (2003) 0.98
Home hemodialysis in Australia: current perspective. Hemodial Int (2008) 0.98
A quarter of a century of adult peritoneal dialysis-related peritonitis at an Australian medical center. Perit Dial Int (2007) 0.98
Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis. J Am Soc Nephrol (2002) 0.97
Blood pressure lowering for the prevention and treatment of diabetic kidney disease. Drugs (2006) 0.97
Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway. J Leukoc Biol (2002) 0.97
Induction of MIF synthesis and secretion by tubular epithelial cells: a novel action of angiotensin II. Kidney Int (2003) 0.96
Heterogeneity of antigen expression explains controversy over glomerular macrophage accumulation in mouse glomerulonephritis. Nephrol Dial Transplant (2003) 0.96
Activation and cellular localization of the p38 and JNK MAPK pathways in rat crescentic glomerulonephritis. Kidney Int (2003) 0.95
p38 Mitogen-activated protein kinase activation and cell localization in human glomerulonephritis: correlation with renal injury. J Am Soc Nephrol (2004) 0.95
Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy. Am J Physiol Renal Physiol (2005) 0.95
Longitudinal body composition changes due to dialysis. Clin J Am Soc Nephrol (2011) 0.94
Socioeconomic disadvantage and kidney disease in the United States, Australia, and Thailand. Am J Public Health (2008) 0.94
Knowledge deficit of patients with stage 1-4 CKD: a focus group study. Nephrology (Carlton) (2014) 0.93
Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients? Nephrology (Carlton) (2008) 0.93
Trends in kidney transplantation in Australia and New Zealand, 1993-2004. Transplantation (2007) 0.93
Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection. Am J Transplant (2003) 0.92
Prospective psychosocial monitoring of living kidney donors using the Short Form-36 health survey: results at 12 months. Transplantation (2004) 0.92
High rates of albuminuria but not of low eGFR in urban indigenous Australians: the DRUID study. BMC Public Health (2011) 0.92